Scientists and others in healthcare around the country should watching closely for what happens in … More the grudge match…
Browsing: threaten
Novo Nordisk and Eli Lilly have established themselves as the market leaders in the obesity drug sector with their GLP-1…
In this week’s edition of InnovationRx, we explore the repercussions of Medicaid cuts, a $400 million investment in obesity research,…
So what can pharmaceutical companies do to navigate these challenging times and mitigate the impact of tariffs on their operations…
Now, with their jobs gone, they worry that the entire project will be jeopardized. The cuts also hit the CDC’s…
On Friday, the National Institutes of Health announced massive cuts to the funding that they will … [+] provide to…
The U.S. government agency, Health Resources & Services Administration (HRSA), has issued a warning to pharmaceutical giant Sanofi regarding its…
